情報源 > 更に詳しい情報[058]
参考文献

(1) 田尻淳一、野口志郎、森田三雄、田丸正明、村上信夫: 抗甲状腺剤による無顆粒球症の発症様式について. 日本内分泌学会雑誌 69: 530-533, 1993
(2) Junichi Tajiri, Shiro Noguchi, Tsukasa Murakami, Nobuo Murakami: Antithyroid Drug-induced Agranulocytosis. The Usefulness of Routine White Blood cell Count Monitoring. Arch Intern Med 150:621-624, 1990
(3) 田尻淳一、野口志郎、森田三雄、田丸正明、村上信夫: 抗甲状腺剤による無顆粒球症:特に“Normal white blood count agranulocytosis”について. 日本内分泌学会雑誌 69: 1013-1016, 1993
(4) Junichi Tajiri, Shiro Noguchi, Nobuo Murakami: Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia. Thyroid 7: 575-578, 1997
(5) Fukata S, Kuma K, Sugawara M: Granulocyte colony-stimulating factor (G-CSF)does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 9: 29-31, 1999
(6) Junichi Tajiri, Shiro Noguchi, Seiichi Okamura, Mitsuo Morita, Masaaki Tamaru, Nobuo Murakami, Yoshiyuki Niho: Granulocyte Colony-Stimulating Factor Treatment of Antithyroid Drug-Induced Granulocytopenia. Arch Intern Med 153: 509-514, 1993
(7) 野口志郎: 抗甲状腺薬による無顆粒球症. モダン・フィジシャン21; 8月号 1071-1072, 2001
(8) Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, Kuma K, Kumagai LF, Nagataki S: Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab. 1993 Nov; 77(5): 1356-60.
(9) Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F: Haematopoietic growth factor in antithyroid- drug-induced agranulocytosis. QJM. 2001 Aug; 94(8): 423-8.
(10) Balkin MS, Buchholtz M, Ortiz J, Green AJ: Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF). Thyroid. 1993; 3: 305-9.
(11) Hamada N, Itoh K, Mototani N, Nishikawa Y, Mimura T, Morii H: Effect of corticosteroids in 10 cases of methimazole induced agranulocytosis. Endocrinol Japon 1981; 28: 823-7.
(12) Retsagi G, Kelly JP, Kaufman DW: Risk of agranulocytosis and aplastic anaemia in relarion to use of antithyroid drugs. Br Med J 1988; 297: 262-5.

もどる